Infectious Disease Fellowship Mentors

​​​​The following provides a list of our research mentors within and outside of the ID division.  Fellows may also work with approved mentors that are not included in these lists.​​

Antimicrobial Resistance

​Name
​Department
​Research Interest
Janelle Ayres, PhD
​Biology
Evolutionary theory to understand microbe regulation of host physiology 
Connie Benson, MD
​Medicine
HIV/AIDS, viral hepatitus, influenza, TB clinical and translational research 
John Bradley, MD
​Pediatrics
Innovative therapies for bacterial and viral infections 
​Aaron Carlin, MD, PhD
​Medicine
Emerging Infectious Diseases, Host-pathogen interactions, genome-wide approaches to understanding pathogenesis; developing novel diagnostics and antimicrobials
Huitung Chu, PhD
​Pathology
Commensal microbe communication with Immune System 
​Shane Crotty, PhD
​Medicine
Vaccine Immunology 
Pieter Dorrestein, PhD
​Skagg School of Pharmacy
Mass Spectrometry characterization of metabolic interactions between cell populations 
​Stephanie Fraley, PhD
​Bioengineering
Mechanisms of cell migration, developing clinical profiling technologies 
Richard Gallo, MD

​Dermatology
Skin biology and innate host defense 
​Jack Gilbert, PhD

​Pediatrics
Hospital microbial community in disease transmission and AMR gene reservoir 
​Christopher Glass, MD, PhD

​Cellular and Molecular Medicine
Regulation of inflammation 
Rob Knight, PhD

​Pediatrics
Computational Biology, Genomics, and Human Microbiome 
Klaus Ley, MD

​Bioengineering
Control of host inflammation in response to infection 
Georgie Liu, MD, PhD

​Pediatrics
Host pathogen interactions of MRSA, GBS, P. acnes 
​James McKerrow, MD, PhD

​Skaggs School of Pharmacy
Discovery and Development of new drugs for neglected tropical diseases 
​Bradley Moore, PhD

​Skaggs School of Pharmacy
Mechanisms in microbial antibiotic production, bioactive natural products 
Victor Nizet, MD

​Pediatrics
Bacterial Pathogenesis, Innate Immunity, novel approaches to combat AMR 
Bernhard Palsson, PhD

​Bioengineering
Systems Biology studies of genome to phenotype 
​Joseph Pogliano, PhD

​Biology
Cell biological tools to study mechanisms of antibiotic targeting of essential cellular processes 
David Pride, MD, PhD

​Pathology
RNA and DNA virus contribution to pathogenesis and effect on host bacterial communities 
Manuela Raffatellu, MD

​Pediatrics
Immune response to mucosal pathogen infection 
Tariq Rana, PhD

​Pediatrics

RNA, stem cell, and chemical biology to discover pathways of human vial infections 
​George Sakoulas, MD

​Pediatrics
Drug synergies with host innate immunity 
​Robert Schooket, MD

​Medicine
Global Infectious Disease, antiviral nanotherapies, phage therapy 
​Sujan Shresta, PhD

​Medicine
Immunology and Virology of mosquito-borne pathogens 
​Aleem Siddiqui, PhD

​Medicine
Molecular Virology, hepatitus viruses and hepatocellular carcinoma 
Nicole Steinmetz, PhD

​Nanoengineering
Design, development, and testing of biologics derived from plant viruses 
Gene Tan, PhD

​Medicine
Virus-host interaction analyses 
​Elizabeth Winzeler, PhD

​Pediatrics
Genome-wide methods identifying antimalarial drug resistance genes 
​Liangfang Zhang, PhD
​Nanoengineering
Biomimetic nanomedicine for drug delivery, detoxification, and vaccination

HIV and Other Pandemics

​​Name
​Department
​Research Interest
Laura Bamford, MD
​Medicine
HIV and HCV treatment and prevention in individuals with a history of opioid use disorder and injection drug use
Connie Benson, MD
​Medicine
Antiretrovirals therapeutics, TB and HIV-related coinfections and comorbidities 
Ajay Bharti, MD
​Medicine
Adverse effects on brain function of co-infections such as hepatitis C, toxoplasmosis, malaria, and latent TB among persons living with HIV 
Kimberly Brouwer, PhD
​School of Public Health
HIV epidemiology, Social and spatial epidemiology among marginalized populations; access to care
Aaron Carlin, Md, PhD
​Medicine
Emerging Infectious Diseases, Host-pathogen interactions, genome-wide approaches to understanding pathogenesis; developing novel diagnostics and antimicrobials
Sumit Chanda, PhD
​Sanford Burnham
​HIV-Host Interactions
Shane Crotty, PhD
​​La Jolla Institue of Immunology
CD4 T cell and germinal center responses to candidate HIV vaccines
Victor DrGruttola, ScD
​Harvard Medicine
Clinical and epidemiological research on HIV infection prevention and treatment
​Ronald Ellis, MD, PhD

​Neuroscience
Neurological complications of HIV infection and substance use
​Richard Garfein, PhD, MPH

​School of Public Health
Investigation and intervention on the infectious disease consequences of substance Use 
Sara Gianella Weibel, MD

​Medicine
Translational virology, molecular biology and immunology, viral co-infections 
John Guatelli, MD

​Medicine
The molecular virology and cell biology of two accessory genes of HIV-1: vpu and nef
​Scott Letendre, MD

​Medicine
Pathogenesis and treatment of HIV comorbidities and neurologic infections
​Susan Little, MD

​Medicine
Translational research related to transmission, prevention and pathogenesis of major viral pathogens 
​David Looney, MD

​Medicine
Gene therapy of HIV/AIDS using lentiviral vectors expressing RNAs (ribozymes, antisense RNA or siRN
Natasha Martin, PhD

​Medicine
Epidemic and economic modeling of HIV and related infectious disease transmission and prevention 
​Sanjay Mehta, MD

​Medicine
Molecular epidemiology of HIV 
David Moore, PhD

​Psychiatry
Co-occuring conditions among persons with HIV, including mood disorders and substance use 
Sheldon, Morris MD

​Medicine
PrEP, STD 
Victor Nizet, MD

​Pediatrics
​Bacterial pathogenesis and the innate immune system, with focus on human streptococcal and staphylococcal infections and emerging antibiotic-resistant pathogens 
Douglas Richman, MD

​Pathology
​HIV Latency
Timothy Rodwell, MD

​Medicine
Infectious disease diagnostics with an emphasis on the development and implementation of rapid molecular diagnostics for TB 
Robert Schooley, MD

​Medicine
Viral pathogenesis and therapy 
Davey Smith, MD, MAD

​Medicine
Sexual transmission of HIV, acute HIV infection, drug resistance, genetic networks, virology
Jamila Stockman, PhD,MPH

​Medicine
HIV prevention and treatment research in the context of gender-based violence, substance abuse, mental health, and socio-structural barriers 
Steffanie Strathdee, PhD

​Medicine
HIV prevention among substance using populations
​Joel Wertheim, PhD
​Medicine
HIV molecular epidemiology

Epidemiology, Behavioral Science, Global Public Health​

​Name
​Department
​Research Interest
​John Ayers, PhD
​Medicine
Online network and social media predictors of public health 
​Annick Borquez, PhD
​Medicine
Substance use and HIV epidemiology 
Angela Bazzi, PhD (nee Robertson)
​Medicine
Improve the utilization of pre-exposure prophylaxis (PrEP) for HIV prevention in PWID 
Aaron Blashill, PhD
​SDSU Psychology
Steroid use, sexual minorities, HIV risk behaviors 
Kimberly Brouwer, PhD
​Family Medicine and Public Health
HIV epidemiology, Spatial and molecular epidemiology among substance user. 
Christina Chambers, PhD, MPH
​Pediatrics
Environmental causes of birth defects 
Heather Corliss, PhD, MPH
​SDSU Public Health
Epidemiology of substance use & mental health, sexual minorities, stigma 
Peter Davidson, PhD
​Medicine
Harm reduction and HIV, overdose, research ethics, mixed methods 
​Victor DeGrutolla, ScD

​Family Medicine and Public Health
Clinical and epidemiological research on HIV infection prevention and treatment 
Rebecca Feilding-Miller, PhD

​Medicine
Social and structural drivers of HIV, gender based violence, and COVID-19 in the United States and sub-Saharan Africa. 
Tommy Gaines, PhD

​Medicine
Statistical and spatial methodologies to examine patterns of infectious disease and illicit substance use 
​Richard Garfein, PhD

​Medicine
Investigation and Intervention on the Infectious Disease Consequences of Substance Use 
​David Grelotti, MD

​Psychiatry
Emergence of illicit drug cocktails mixed with ARVs, treatment of HIV psychosocial syndemics 
Keith Horvath, PhD

​Psychology
Health interventions to address the HIV prevention and care continuum for sexual minority men. 
Sonia Jain, PhD

​Family Medicine and Public Health
Biostatistics and clinical trials for HIV/infectious diseases populations 
Susan Keine, PhD

​SDSU Public Health
Alcohol and HIV prevention, substance use and HIV co-infections, maternal/child health
Natasha Martin, PhD

​Medicine
Epidemic and economic modeling of HIV and related infectious disease transmission and prevention 
Thomas Patteron, PhD

​Psychiatry
Behavioral interventions among substance users, RCT design and analysis, psychometrics 
​Heather Pines, PhD

​SDSU Medicine
HIV/STI transmission dynamics among substance users, molecular epidemiology, Social network analyses 
Eileen Pitpitan, PhD

SDSU Social Work
Structural interventions, mediator/moderator analyses 
​Elizabeth Reed, ScD

​SDSU Public Health
Evaluation of economic and structural interventions; HIV, gender-based violence, and substance use 
Mark Reed, PhD

​SDSU Social Work
Substance use etiology, young adult use trajectories, person-environment and gene-environment interactions and substance use 
​Yuyan Shi, PhD

​Public Health
Regulatory, physical, economics, and marketing environments in relation to drug abuse and related consequences 
Jay Silverman, PhD

​Medicine
​HIV risks related to sex trafficking and substance 
use, gender-based violence, adolescent HIV/STI prevention 
​Britt Skaathun, PhD

​Medicine
Using social, sexual, substance and molecular networks for HIV prevention and care 
David Smith, PD, MAS

​Medicine
Sexual transmission of HIV, acute HIV infection, drug resistance, genetic networks, virology 
Laramie Smith, PhD

​Medicine
Access to HIV care among substance users 
Steffanie Strathdee, PhD

​Medicine
​Epidemiology of bloodborne pathogens, injection drug use, 
design and evaluation of behavioral and structural interventions 
David Strong, PhD

​Public Health
Smoking, behavioral interventions, scale development 
​Jamila Stockman, PhD

​Medicine
Gender-based violence and HIV; HIV and stress 
Kiyomi Tsuyuki, PhD

​Medicine
Socio-structural barriers and syndemic barriers to HIV testing, ART adherence, and HIV viral suppression 
Lianne Urada, PhD

​SDSU Social Work
Homelessness during COVID-19: Exploring the usability and effects of telehealth interventions on buprenorphine treatment 
Vaida Florin, PhD

​Family Medicine and Public Health
Mixed-effects models, proportional hazards mixed-effects models, model selection, and clinical trials 
Tatyana Vasylyeva, PhD

​Medicine
Phylodynamics and phylogeography to investigate how social, behavioral and biological factors affect HIV epidemics 
​Daniel Werb, PhD

​Medicine
Initiation of drug use and HIV; drug policy evaluation 
Adriane Wynn, PhD

​Medicine
Harmful alcohol use, HIV, and other sexually transmitted infections in resource-limited 
Maria Zuniga, PhD​
​SDSU Socail Work
Behavior among HIV+ Latino/a substance users, HIV stigma, qualitative analysis 


Show additional content areas below